Intron-A/Aldara Combination Therapy for Basal Cell Carcinoma (BCC)

Verified by: The University of Texas Health Science Center, Houston, February 2011
First Received: December 21, 2007 | Last Updated: February 17, 2011 | Phase: Phase 4 | Start Date: December 2007
Overall Status: Active, not recruiting | Estimated Enrollment: 49
  • …
  • Tell a FriendPrint

A trial to see if BCC excluding the scalp and face can be treated successfully with a combination therapy of Intron-A and Aldara...

Brief Summary

Official Title: “Intron-A/Aldara Combination Therapy for BCC Excluding the Face and Scalp”

A trial to see if BCC excluding the scalp and face can be treated successfully with a combination therapy of Intron-A and Aldara.

  • Study Type: Interventional
  • Study Design: Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
  • Study Primary Completion Date: September 2011

Intervention(s) in this Clinical Trial

  • Biological: Imiquimod and Interferon alpha
    • Imiquimod first two weeks and last two weeks. Interferon middle five weeks.

Arms, Groups and Cohorts in this Clinical Trial

  • Experimental: Treated

Outcome Measures for this Clinical Trial

Primary Measures

  • resolution of basal cell carcinoma
    • Time Frame: 2 years
      Safety Issue?: No

Secondary Measures

  • resolution of basal cell carcinoma at a lower cost and less inflammation.
    • Time Frame: 2 years
      Safety Issue?: No

Criteria for Participation in this Clinical Trial

Inclusion Criteria:

  • Nodular or superficial basal cell carcinoma on the skin excluding scalp or face

Exclusion Criteria:

  • Pregnancy

Gender Eligibility for this Clinical Trial: Both

Minimum Age for this Clinical Trial: N/A

Maximum Age for this Clinical Trial: N/A

Are Healthy Volunteers Accepted for this Clinical Trial?: No

Clinical Trial Investigator Information

Lead Investigator: The University of Texas Health Science Center, Houston Other

Overall Clinical Trial Officials and Contacts

Stephen B Tucker, M.D. Principal Investigator University of Texas Health Science Center of Houston Dermatology Clinic  

Additional Information

Information obtained from ClinicalTrials.gov on February 12, 2012

Link to the current ClinicalTrials.gov record. http://clinicaltrials.gov/show/NCT00581425

Study ID Number: HSC-MS-06-0478

ClinicalTrials.gov Identifier: NCT00581425

Health Authority: United States: Institutional Review Board

  • …
  • Tell a FriendPrint

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is:
http://clinicaltrialsfeeds.org/clinical-trials/show/NCT00581425